BOSTON (MarketWatch) -- Biotech and pharmaceutical stocks rose in early action Wednesday as shares of Critical Therapeutics soared on news that it had signed a deal with an affiliate of German conglomerate Merck KGaA to co-promote the asthma drug Zyflo.